01/29/17Katalyst Healthcares & Life Sciences
1
ARGUS Screen SHOTS
General Tab
GENERAL SCREENGENERAL SCREEN
Entering
 ‘General information’
 ‘Study information’
 ‘Reporter information’
 ‘Literature information’
into ARGUS SAFETY
01/29/17Katalyst Healthcares & Life Sciences
2
GENERAL SCREENGENERAL SCREEN
01/29/17Katalyst Healthcares & Life Sciences
3
GENERAL INFORMATION
Report type:
Spontaneous Report
Clinical Trial
Literature Case
01/29/17Katalyst Healthcares & Life Sciences
4
Reporter Type
 Indicates source of report.
 Only one report type per case.
 Used by ARGUS Safety workflow, expediting and PSUR
generation.
 Case report type can change based on follow-up information
01/29/17Katalyst Healthcares & Life Sciences
5
GENERAL INFORMATION
Data already entered during book-in:
 Country of incidence
 Initial receipt date
 Central receipt date
Other fields:
 Case Status (shows work flow status)
 Fields referring to FU information (see chapter on FU)
01/29/17Katalyst Healthcares & Life Sciences
6
GENERAL INFORMATION
Case Category:
 Important in searching
 Some case categories can only be used with certain
report types (validation check)
 Assists in filtering cases
01/29/17Katalyst Healthcares & Life Sciences
7
CASE CATEGORY
Spontaneous Report:
 Device spontaneous report
Clinical Trial:
 Clinical trial
 Compassionate Use
 Device trial
 Epidemiological study
 Intensive monitoring project
 Non-Novartis trial
 Novartis patient registry
 Non-Novartis patient registry
 Other studies
 Post Marketing Surveillance
 Protocol exempted SAE
01/29/17Katalyst Healthcares & Life Sciences
8
CASE CATEGORY
Other case categories:
 Beneficial effect unexpected
 Deactivated Case
 Deactivated Case – other MAH
 Lactation related
 Legal case
 Multiple patient case (used for legacy cases)
 Pregnancy prospectively received
 Pregnancy retrospectively received
 Pregnancy no AE
 Fwd to Tech OP
01/29/17Katalyst Healthcares & Life Sciences
9
Reporter Information:
 Reporter name and address must be collected if
possible.
 Indicate in the narrative if the report is from a
consumer, physician, health authority or other
company.
01/29/17Katalyst Healthcares & Life Sciences
10
Reporter Information:
Missing reporter last name:
 Do not leave ‘Last Name’ field empty but enter ‘Not available’ or
‘Anonymous’
 The “Protect Confidentiality” checkbox must be checked for
such cases
 This also applies to cases received from Health Authorities and
other intermediary reporters, when the primary reporter’s name is
not provided.
01/29/17Katalyst Healthcares & Life Sciences
11
Reporter Information
‘Health Care Professional’ field
Select YES if the report was received
 from a health professional.
 from Health Authorities
 from scientific literature
 Qualifications of source are not identifiable
Select No if report was received from
 Consumer
 Lawyer/attorney
 Other company
Radio buttons are linked with ‘Reporter type
01/29/17Katalyst Healthcares & Life Sciences
12
Reporter Information
Other reporter information fields:
 Reporter type (linked with HCP radio buttons and ‘Protect
confidentiality’ tick box)
 Intermediary e.g.
Regulatory Authority Customer response
Pharmaceutical Company Medical Affairs
Local Drug Safety Center Scientific Operations
Sales Representative Technical Operations
 Report sent to Regulatory Authority by Reporter ?
01/29/17Katalyst Healthcares & Life Sciences
13
Reporter Information:
‘Protect Confidentiality’ tick box is checked for
 Consumer/patient reports or reports from relatives of
consumer/patient
 Case where intermediary does not provide initial reporter’s
name (anonymous reporter, HA reports, reports from other
company)
 For all German and French cases
 For all correspondence contacts
 “Name and address withheld” will be printed on regulatory
forms.
01/29/17Katalyst Healthcares & Life Sciences
14
Reporter Information:
Primary reporter/correspondence contact
 Primary Reporter is the ACTUAL REPORTER e.g. patient, physician,
pharmacist, etc.
 Primary Reporter will be printed on regulatory forms.
 A Primary Reporter can also be the Correspondence Contact.
 Correspondence Contacts not marked as Primary Reporter can
be
 the patient’s physician name and address when provided by
patient
 Health Authority, License partner or other intermediary
 correspondence address in literature reports.
01/29/17Katalyst Healthcares & Life Sciences
15
Guidance on primary in consumer cases was added:
• AE is initially reported by a consumer, the consumer is entered as
primary reporter.
• When the case is later confirmed by a Healthcare Professional, the
HP becomes the ‘Primary reporter’ and correspondence contact.
• If the opposite occurs ie additional information is provided by the
consumer after an initial report has been submitted by a HP, the HP
remains the ‘Primary reporter’ and the correspondence contact.
Reporter Information:
01/29/17Katalyst Healthcares & Life Sciences
16
Reporter Information:
Specific scenarios
Consumer is health professional
 Enter similar to consumer reports
 Select ‘Health Care Professional’ YES
 Check ‘Protect Confidentiality’ box
01/29/17Katalyst Healthcares & Life Sciences
17
Reporter Information:
Specific scenarios… many more
please refer to MAP
01/29/17Katalyst Healthcares & Life Sciences
18
Literature Reports:
 Entering the Literature Information
 If you select ‘Literature’ as a report type the following screen will be displayed:
01/29/17Katalyst Healthcares & Life Sciences
19
Pre-configured Studies
SPECIFIC FIELDS AND PROCEDURESSPECIFIC FIELDS AND PROCEDURES
01/29/17
Katalyst Healthcares & Life Sciences
20
Pre-configured Study information
 Protocol ID - Populated from book-inProtocol ID - Populated from book-in
 Study ID - Populated from book-inStudy ID - Populated from book-in
 Centre ID - Study site - centres are configured for eachCentre ID - Study site - centres are configured for each
specific study and can be selected from a drop down box.specific study and can be selected from a drop down box.
 In the product screen, depending on the trial design, the drug
may have to be reselected from the administered drug field
and the indication may have to be recoded.
01/29/17Katalyst Healthcares & Life Sciences
21
Case Categories:Case Categories:
 In addition to adverse event related case categories,
for PMS/Registry cases, you have to select a
specific case category
- Post Marketing Surveillance
- Novartis Patient Registry
- Non-Novartis Patient Registry
- Intensive Monitoring Project
01/29/17Katalyst Healthcares & Life Sciences
22
License Partner
And
other Company Specifics
01/29/17
Katalyst Healthcares & Life Sciences
23
License Partner Cases:
 Enter the initial reporter as a primary reporter.
 If the reporter is a health care professional or not specified,
enter as a health care professional.
 If it has been stated that the reporter is not a HCP, enter as
appropriate eg. Consumer, lawyer or relative.
 Enter the license partner as a second tab and mark as
Correspondence Contact and tick Protect confidentiality
 The licence partner must be selected using the ‘Select’
button.
 If not configured, contact your local administrator.
01/29/17Katalyst Healthcares & Life Sciences
24
Cases from other companies
 Enter the initial reporter as a primary reporter
 If the reporter is a health care professional or is not specified enter
as a HCP.
 If stated that the reporter is not a health care professional, enter as
appropriate, eg. Consumer, lawyer or relative.
 Enter the Pharmaceutical company as a second tab and mark as
Correspondence Contact and tick Protect confidentiality.
 Health Care Professional ‘No’ should be selected for the other
company
01/29/17Katalyst Healthcares & Life Sciences
25
Thank YouThank You
&&
QuestionsQuestions
01/29/17
26
Contact:
Katalyst Healthcare’s & Life Sciences
South Plainfield, NJ, USA 07080.
E-Mail: info@KatalystHLS.comKatalyst Healthcares & Life Sciences

Argus Screen Shots General Tab - Katalyst HLS

  • 1.
    01/29/17Katalyst Healthcares &Life Sciences 1 ARGUS Screen SHOTS General Tab
  • 2.
    GENERAL SCREENGENERAL SCREEN Entering ‘General information’  ‘Study information’  ‘Reporter information’  ‘Literature information’ into ARGUS SAFETY 01/29/17Katalyst Healthcares & Life Sciences 2
  • 3.
    GENERAL SCREENGENERAL SCREEN 01/29/17KatalystHealthcares & Life Sciences 3
  • 4.
    GENERAL INFORMATION Report type: SpontaneousReport Clinical Trial Literature Case 01/29/17Katalyst Healthcares & Life Sciences 4
  • 5.
    Reporter Type  Indicatessource of report.  Only one report type per case.  Used by ARGUS Safety workflow, expediting and PSUR generation.  Case report type can change based on follow-up information 01/29/17Katalyst Healthcares & Life Sciences 5
  • 6.
    GENERAL INFORMATION Data alreadyentered during book-in:  Country of incidence  Initial receipt date  Central receipt date Other fields:  Case Status (shows work flow status)  Fields referring to FU information (see chapter on FU) 01/29/17Katalyst Healthcares & Life Sciences 6
  • 7.
    GENERAL INFORMATION Case Category: Important in searching  Some case categories can only be used with certain report types (validation check)  Assists in filtering cases 01/29/17Katalyst Healthcares & Life Sciences 7
  • 8.
    CASE CATEGORY Spontaneous Report: Device spontaneous report Clinical Trial:  Clinical trial  Compassionate Use  Device trial  Epidemiological study  Intensive monitoring project  Non-Novartis trial  Novartis patient registry  Non-Novartis patient registry  Other studies  Post Marketing Surveillance  Protocol exempted SAE 01/29/17Katalyst Healthcares & Life Sciences 8
  • 9.
    CASE CATEGORY Other casecategories:  Beneficial effect unexpected  Deactivated Case  Deactivated Case – other MAH  Lactation related  Legal case  Multiple patient case (used for legacy cases)  Pregnancy prospectively received  Pregnancy retrospectively received  Pregnancy no AE  Fwd to Tech OP 01/29/17Katalyst Healthcares & Life Sciences 9
  • 10.
    Reporter Information:  Reportername and address must be collected if possible.  Indicate in the narrative if the report is from a consumer, physician, health authority or other company. 01/29/17Katalyst Healthcares & Life Sciences 10
  • 11.
    Reporter Information: Missing reporterlast name:  Do not leave ‘Last Name’ field empty but enter ‘Not available’ or ‘Anonymous’  The “Protect Confidentiality” checkbox must be checked for such cases  This also applies to cases received from Health Authorities and other intermediary reporters, when the primary reporter’s name is not provided. 01/29/17Katalyst Healthcares & Life Sciences 11
  • 12.
    Reporter Information ‘Health CareProfessional’ field Select YES if the report was received  from a health professional.  from Health Authorities  from scientific literature  Qualifications of source are not identifiable Select No if report was received from  Consumer  Lawyer/attorney  Other company Radio buttons are linked with ‘Reporter type 01/29/17Katalyst Healthcares & Life Sciences 12
  • 13.
    Reporter Information Other reporterinformation fields:  Reporter type (linked with HCP radio buttons and ‘Protect confidentiality’ tick box)  Intermediary e.g. Regulatory Authority Customer response Pharmaceutical Company Medical Affairs Local Drug Safety Center Scientific Operations Sales Representative Technical Operations  Report sent to Regulatory Authority by Reporter ? 01/29/17Katalyst Healthcares & Life Sciences 13
  • 14.
    Reporter Information: ‘Protect Confidentiality’tick box is checked for  Consumer/patient reports or reports from relatives of consumer/patient  Case where intermediary does not provide initial reporter’s name (anonymous reporter, HA reports, reports from other company)  For all German and French cases  For all correspondence contacts  “Name and address withheld” will be printed on regulatory forms. 01/29/17Katalyst Healthcares & Life Sciences 14
  • 15.
    Reporter Information: Primary reporter/correspondencecontact  Primary Reporter is the ACTUAL REPORTER e.g. patient, physician, pharmacist, etc.  Primary Reporter will be printed on regulatory forms.  A Primary Reporter can also be the Correspondence Contact.  Correspondence Contacts not marked as Primary Reporter can be  the patient’s physician name and address when provided by patient  Health Authority, License partner or other intermediary  correspondence address in literature reports. 01/29/17Katalyst Healthcares & Life Sciences 15
  • 16.
    Guidance on primaryin consumer cases was added: • AE is initially reported by a consumer, the consumer is entered as primary reporter. • When the case is later confirmed by a Healthcare Professional, the HP becomes the ‘Primary reporter’ and correspondence contact. • If the opposite occurs ie additional information is provided by the consumer after an initial report has been submitted by a HP, the HP remains the ‘Primary reporter’ and the correspondence contact. Reporter Information: 01/29/17Katalyst Healthcares & Life Sciences 16
  • 17.
    Reporter Information: Specific scenarios Consumeris health professional  Enter similar to consumer reports  Select ‘Health Care Professional’ YES  Check ‘Protect Confidentiality’ box 01/29/17Katalyst Healthcares & Life Sciences 17
  • 18.
    Reporter Information: Specific scenarios…many more please refer to MAP 01/29/17Katalyst Healthcares & Life Sciences 18
  • 19.
    Literature Reports:  Enteringthe Literature Information  If you select ‘Literature’ as a report type the following screen will be displayed: 01/29/17Katalyst Healthcares & Life Sciences 19
  • 20.
    Pre-configured Studies SPECIFIC FIELDSAND PROCEDURESSPECIFIC FIELDS AND PROCEDURES 01/29/17 Katalyst Healthcares & Life Sciences 20
  • 21.
    Pre-configured Study information Protocol ID - Populated from book-inProtocol ID - Populated from book-in  Study ID - Populated from book-inStudy ID - Populated from book-in  Centre ID - Study site - centres are configured for eachCentre ID - Study site - centres are configured for each specific study and can be selected from a drop down box.specific study and can be selected from a drop down box.  In the product screen, depending on the trial design, the drug may have to be reselected from the administered drug field and the indication may have to be recoded. 01/29/17Katalyst Healthcares & Life Sciences 21
  • 22.
    Case Categories:Case Categories: In addition to adverse event related case categories, for PMS/Registry cases, you have to select a specific case category - Post Marketing Surveillance - Novartis Patient Registry - Non-Novartis Patient Registry - Intensive Monitoring Project 01/29/17Katalyst Healthcares & Life Sciences 22
  • 23.
    License Partner And other CompanySpecifics 01/29/17 Katalyst Healthcares & Life Sciences 23
  • 24.
    License Partner Cases: Enter the initial reporter as a primary reporter.  If the reporter is a health care professional or not specified, enter as a health care professional.  If it has been stated that the reporter is not a HCP, enter as appropriate eg. Consumer, lawyer or relative.  Enter the license partner as a second tab and mark as Correspondence Contact and tick Protect confidentiality  The licence partner must be selected using the ‘Select’ button.  If not configured, contact your local administrator. 01/29/17Katalyst Healthcares & Life Sciences 24
  • 25.
    Cases from othercompanies  Enter the initial reporter as a primary reporter  If the reporter is a health care professional or is not specified enter as a HCP.  If stated that the reporter is not a health care professional, enter as appropriate, eg. Consumer, lawyer or relative.  Enter the Pharmaceutical company as a second tab and mark as Correspondence Contact and tick Protect confidentiality.  Health Care Professional ‘No’ should be selected for the other company 01/29/17Katalyst Healthcares & Life Sciences 25
  • 26.
    Thank YouThank You && QuestionsQuestions 01/29/17 26 Contact: KatalystHealthcare’s & Life Sciences South Plainfield, NJ, USA 07080. E-Mail: info@KatalystHLS.comKatalyst Healthcares & Life Sciences

Editor's Notes

  • #9 Clinical trial case category mainly used for Non Novartis studies, compassionate use and pregnancy.
  • #12 If the investigator’s name and address is not recorded on the SAE, search to see if there are previous reports from the centre. Note on the case that the investigator’s name and address was taken from previous case. If there are no previous SAE’s, record the “last name” as “Not available” and request investigator’s full name and address.
  • #13 Pharma Horsham clinical trials: All reports are from health care professionals.
  • #14 For clinical trial cases, the reporter type is usually investigator (sometimes nurse). Both are health care professionals and the case will not save if the health care professional box is not ticked.
  • #22 Other ID is not currently used by Pharma Horsham, but may be used to differentiate between different cohorts (groups of patients) in the same study. Be careful when entering week number reported, as it should refer to week of study not of calendar year.
  • #23 Clinical trial case categories are mainly used for Non Novartis studies, compassionate use and pregnancy. Compassionate use cases, expanded access cases and Non-Novartis studies are all given dummy configurations. This helps with searching and retrievals therefore helping to eliminate duplicates.